The Influence of Seat Height on Hemiplegic-pattern Propulsion of Manual Wheelchairs

September 9, 2020 updated by: Lee Kirby
This study evaluates the effect of seat height on hemiplegic-pattern wheelchair propulsion. Each subject will act as their own control and measures will be obtained in a one sixty minute session. Five seat heights relative to the subject's leg length will be measured in a random order to see the effect on forward and backwards wheelchair propulsion.

Study Overview

Detailed Description

Many people who have suffered a stroke require a wheelchair for mobility. Hemiplegia is a common result of stroke.Many people with hemiplegia propel themselves using their sound-side arms and legs ("hemiplegic-pattern propulsion") in manual wheelchairs.Often people using this pattern are prescribed wheelchairs with a reduced seat height to facilitate foot propulsion. Despite the seeming obviousness of the need to lower the seat height for people who use foot propulsion,there is little available evidence to help establish optimal wheelchair seat height. The study objective is to test the hypothesis that there is an optimum wheelchair seat height (expressed as a percentage of the lower leg length) for hemiplegic-pattern wheelchair propulsion. The investigators expect that the optimum seat height will be lower than that usually used for wheelchairs that are hand-propelled.

A single-subject design with able-bodied participants will be used to investigate 5 randomized seat heights. The 5 seat heights will be set relative to the subjects leg length at a single 60 minute data collection session All measures will be obtained during one session. The optimal seat height will be chosen based on wheelchair propulsion speed, push frequency and effectiveness over 10m going forward on smooth surface, and 5m going backwards over a soft surface.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 4K4
        • Nova Scotia Rehabilitation and Arthritis Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • willing to participate
  • is right-hand dominant (to simplify wheelchair and laboratory set-up)
  • has a subjective unshod height of ≤ 183 cm (6'0")
  • is able to be comfortably seated in the manual wheelchair used for the study
  • is 18 years of age or older, is alert and cooperative
  • is competent to provide informed consent
  • is able to communicate in English
  • does not have an unstable medical condition

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Seat Height Intervention
Randomly assigned 5 wheelchair seat heights ranging from very low (2" below) to very high (2" above) the lower leg length of the participant.
Seat height set relative to participant's leg length with neutral set at the measured lower leg length
Seat height set relative to participant's leg length, 2" below the measured lower leg length
Seat height set relative to participant's leg length, 1" below the measured lower leg length
Seat height set relative to participant's leg length, 2" above the measured lower leg length
Seat height set relative to participant's leg length, 1" above the measured lower leg length

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
speed (m/s)
Time Frame: same day measure obtained immediately after seat adjustment, approximately 10 minutes
wheelchair propulsion speed over 10 m forward and 5 m backward
same day measure obtained immediately after seat adjustment, approximately 10 minutes
push frequency (cycles per second)
Time Frame: same day measure obtained immediately after seat adjustment, approximately 10 minutes
number of foot cycles completed over the 10 m forward and 5 m backward
same day measure obtained immediately after seat adjustment, approximately 10 minutes
Propulsion effectiveness
Time Frame: same day measure obtained immediately after seat adjustment, approximately 10 minutes
distance travelled per foot propulsion cycle
same day measure obtained immediately after seat adjustment, approximately 10 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
forward propulsion wheelchair skills test score
Time Frame: same day measure obtained immediately after seat adjustment, approximately 10 minutes
fail, pass with difficulty or pass for wheeling forward 10 m
same day measure obtained immediately after seat adjustment, approximately 10 minutes
propulsion difficulty questionnaire
Time Frame: same day measure obtained immediately after seat adjustment, approximately 10 minutes
Investigator developed questionnaire asking how difficult it was to perform the propulsion test. The participant will self-report his/her level of difficulty for this skill using a five-point Likert scale (1 =very easy, 2=somewhat easy, 3=neither easy nor difficult, 4= somewhat difficult and 5=very difficult). A single number will be reported.
same day measure obtained immediately after seat adjustment, approximately 10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Lee Kirby, MD, Nova Scotia Health Authority, Dalhousie University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2018

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

October 30, 2017

First Submitted That Met QC Criteria

October 31, 2017

First Posted (Actual)

November 6, 2017

Study Record Updates

Last Update Posted (Actual)

September 11, 2020

Last Update Submitted That Met QC Criteria

September 9, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 1022716

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegia

Clinical Trials on Neutral seat height

3
Subscribe